Zhejiang Huaye Plastics Machinery
301616
Zhejiang Huayuan Auto Technology
301535
Alnera Aluminium
301613
4
Tibet Duo Rui Pharmaceutical
301075
5
Shenzhen Vital New Material
301319
CN Stock MarketDetailed Quotes
688089 Cabio Biotech(Wuhan)
- 24.45
- -0.67-2.67%
Trading Mar 31 10:57 CST
4.12BMarket Cap33.13P/E (TTM)
24.94High24.39Low18.62KlotVolume24.88Open25.12Pre Close45.84MTurnover1.11%Turnover Ratio33.13P/E (Static)168.31MShares30.1252wk High2.64P/B4.12BFloat Cap11.8452wk Low30.14Limit Up168.31MShs Float48.85Historical High20.10Limit Down2.19%Amplitude9.78Historical Low0.20Dividend TTM24.62Avg Price7.90KlotAsk0.82%Div YieldTTM100Lot Size9.89KlotBid
Cabio Biotech(Wuhan) Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 25.19%555.59M | 19.19%387.15M | 31.23%260.83M | 33.34%117.02M | 2.39%443.8M | 18.88%324.83M | 16.13%198.76M | 16.18%87.76M | 23.44%433.42M | 9.34%273.24M |
| Operating revenue | 25.19%555.59M | 19.19%387.15M | 31.23%260.83M | 33.34%117.02M | 2.39%443.8M | 18.88%324.83M | 16.13%198.76M | 16.18%87.76M | 23.44%433.42M | 9.34%273.24M |
| Total operating cost | 22.67%434.91M | 17.61%316.71M | 23.53%204.11M | 20.11%95.74M | 5.32%354.55M | 27.70%269.29M | 27.11%165.23M | 28.27%79.71M | 34.94%336.63M | 31.14%210.89M |
| Operating cost | 22.54%313.28M | 22.01%233.13M | 28.90%151.05M | 28.73%69.63M | 1.94%255.64M | 26.87%191.07M | 25.54%117.18M | 36.23%54.09M | 43.06%250.77M | 31.89%150.61M |
| Operating tax surcharges | -14.62%5.45M | 1.74%4.02M | 15.67%2.33M | -3.76%996.74K | 39.98%6.38M | 50.53%3.95M | 82.57%2.01M | 191.81%1.04M | -8.95%4.56M | -20.76%2.62M |
| Operating expense | 4.64%31.83M | 11.88%21.75M | 21.31%15.36M | 26.24%8.01M | 22.60%30.42M | 0.13%19.44M | -0.11%12.66M | -6.68%6.34M | 40.23%24.81M | 39.33%19.42M |
| Administration expense | 56.31%40.52M | -18.27%24.12M | -17.59%15.57M | -20.63%7.2M | -34.39%25.92M | 3.20%29.51M | 6.60%18.9M | 7.41%9.07M | 61.31%39.51M | 69.81%28.59M |
| Financial expense | -68.78%-4.06M | 79.15%-603.83K | 37.89%-2.08M | -132.85%-542.49K | 84.28%-2.41M | 82.65%-2.9M | 64.78%-3.35M | 130.09%1.65M | -287.61%-15.31M | -246.39%-16.69M |
| -Interest expense (Financial expense) | -33.17%397.94K | -34.12%318.83K | -44.61%224.92K | -57.13%115.73K | 62.65%595.49K | -16.80%483.93K | -30.18%406.09K | --269.96K | 4.18%366.11K | --581.64K |
| -Interest Income (Financial expense) | 11.40%-1.85M | 36.45%-1.09M | 35.50%-868.35K | 63.96%-497.39K | 61.60%-2.09M | 26.16%-1.71M | 42.03%-1.35M | -34.26%-1.38M | 22.13%-5.44M | 56.15%-2.32M |
| Research and development | 24.12%47.91M | 21.58%34.3M | 22.72%21.89M | 38.97%10.45M | 19.51%38.6M | 7.13%28.21M | 21.57%17.83M | 22.79%7.52M | 4.36%32.3M | 51.75%26.33M |
| Credit Impairment Loss | 165.61%4.61M | 210.54%6.01M | 388.01%8.88M | 105.52%1.96M | 55.11%-7.03M | -406.75%-5.43M | -380.03%-3.08M | -67.81%952.56K | -155.79%-15.67M | 131.56%1.77M |
| Asset Impairment Loss | -54.32%-13.19M | 53.94%-2.99M | 16.72%-4.02M | -544.24%-566.37K | 75.76%-8.55M | -1,696.23%-6.49M | -9,823.77%-4.83M | 597.26%127.49K | -882.95%-35.28M | -317.17%-361.06K |
| Other net revenue | ||||||||||
| Fair value change income | 110.33%267.18K | 159.68%249.27K | 164.39%718.01K | -47.55%-644.1K | 49.37%-2.59M | 89.03%-417.71K | 55.88%-1.12M | -278.34%-436.54K | -617.35%-5.11M | -6.80%-3.81M |
| Invest income | -68.57%1.67M | -81.50%717.43K | -98.32%60.86K | -99.22%14.29K | 215.46%5.32M | -47.86%3.88M | 9.64%3.63M | -17.11%1.84M | -82.88%1.69M | -31.70%7.44M |
| -Including: Investment income associates | 136.17%752.16K | 55.67%-310.67K | 71.99%-136.4K | ---- | 69.37%-2.08M | 28.85%-700.78K | 50.56%-486.96K | ---- | -358.94%-6.79M | -10.91%-984.96K |
| Asset deal income | -105.66%-2.66K | ---- | ---- | ---- | 2,124.30%47.09K | --46.35K | --46.35K | ---- | --2.12K | ---- |
| Other revenue | 141.52%12.45M | 185.44%8.89M | 729.92%8.51M | 161.61%1.43M | -40.43%5.15M | -16.05%3.11M | -62.74%1.03M | -18.31%547.44K | 37.37%8.65M | 130.09%3.71M |
| Operating profit | 55.00%126.48M | 65.83%83.31M | 142.73%70.87M | 111.77%23.47M | 59.74%81.61M | -29.35%50.24M | -36.17%29.2M | -43.19%11.08M | -56.39%51.09M | -22.99%71.11M |
| Add:Non operating Income | -17.00%20.24M | -17.13%15.2M | -16.39%10.1M | -18.85%5.02M | -22.31%24.39M | -3.80%18.34M | -3.46%12.08M | 2.63%6.18M | -19.21%31.4M | -36.97%19.06M |
| Less:Non operating expense | 15.20%6.91M | 40.95%4.22M | 18.95%2.94M | -59.52%427.84K | 37.97%6M | 28.41%3M | 65.30%2.47M | 257.82%1.06M | 9.66%4.35M | -3.50%2.33M |
| Total profit | 39.82%139.82M | 43.77%94.29M | 101.07%78.04M | 73.12%28.06M | 27.98%100M | -25.34%65.58M | -31.63%38.81M | -35.78%16.21M | -48.61%78.14M | -26.90%87.84M |
| Less:Income tax cost | 44.43%19.69M | 55.20%13.12M | 94.08%11.72M | 63.74%4.39M | -17.66%13.63M | -32.53%8.46M | -31.38%6.04M | -16.95%2.68M | -20.26%16.56M | -21.61%12.53M |
| Net profit | 39.09%120.13M | 42.07%81.16M | 102.36%66.32M | 74.98%23.67M | 40.25%86.37M | -24.14%57.13M | -31.67%32.77M | -38.54%13.53M | -53.10%61.58M | -27.72%75.3M |
| Net profit from continuing operation | 39.09%120.13M | 42.07%81.16M | 102.36%66.32M | 74.98%23.67M | 40.25%86.37M | -24.14%57.13M | -31.67%32.77M | -38.54%13.53M | -53.10%61.58M | -27.72%75.3M |
| Less:Minority Profit | 18.46%-4.08M | 17.01%-2.73M | 24.40%-1.57M | 17.94%-637.83K | -79.39%-5.01M | -28.33%-3.29M | -0.72%-2.07M | 35.85%-777.23K | -202.79%-2.79M | -179.29%-2.56M |
| Net profit of parent company owners | 35.94%124.21M | 38.86%83.89M | 94.82%67.89M | 69.93%24.31M | 41.95%91.37M | -22.41%60.41M | -30.34%34.85M | -38.40%14.31M | -49.94%64.37M | -22.87%77.87M |
| Earning per share | ||||||||||
| Basic earning per share | 37.04%0.74 | 38.89%0.5 | 90.48%0.4 | 55.56%0.14 | 42.11%0.54 | -44.62%0.36 | -30.00%0.21 | -52.63%0.09 | -64.49%0.38 | -22.62%0.65 |
| Diluted earning per share | 37.04%0.74 | 38.89%0.5 | 90.48%0.4 | 55.56%0.14 | 42.11%0.54 | -44.62%0.36 | -30.00%0.21 | -52.63%0.09 | -64.49%0.38 | -22.62%0.65 |
| Other composite income | 83.46%-1.25K | 185.05%12.02K | 37.12%-10.47K | -680.24 | 82.56%-7.54K | 42.93%-14.13K | 32.78%-16.64K | -424.07%-43.24K | 85.55%-24.76K | |
| Other composite income of parent company owners | 83.46%-1.25K | 185.05%12.02K | 37.12%-10.47K | ---680.24 | 82.56%-7.54K | 42.93%-14.13K | 32.78%-16.64K | ---- | -424.07%-43.24K | 85.55%-24.76K |
| Total composite income | 39.10%120.13M | 42.13%81.17M | 102.43%66.31M | 74.98%23.67M | 40.34%86.36M | -24.13%57.11M | -31.67%32.76M | -37.17%13.53M | -53.13%61.54M | -27.62%75.28M |
| Total composite income of parent company owners | 35.95%124.21M | 38.91%83.9M | 94.88%67.88M | 69.93%24.31M | 42.03%91.37M | -22.41%60.4M | -30.34%34.83M | -37.10%14.31M | -49.97%64.33M | -22.76%77.84M |
| Total composite income of minority owners | 18.46%-4.08M | 17.01%-2.73M | 24.40%-1.57M | 17.94%-637.83K | -79.39%-5.01M | -28.33%-3.29M | -0.72%-2.07M | 35.85%-777.23K | -202.79%-2.79M | -179.29%-2.56M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | -- | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.